Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

HER2-specific affibody-conjugated thermosensitive liposomes (Affisomes) for improved delivery of anticancer agents.

Puri A, Kramer-Marek G, Campbell-Massa R, Yavlovich A, Tele SC, Lee SB, Clogston JD, Patri AK, Blumenthal R, Capala J.

J Liposome Res. 2008;18(4):293-307. doi: 10.1080/08982100802457377 .

2.

Hyperthermia-triggered intracellular delivery of anticancer agent to HER2(+) cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2(+) affisomes).

Smith B, Lyakhov I, Loomis K, Needle D, Baxa U, Yavlovich A, Capala J, Blumenthal R, Puri A.

J Control Release. 2011 Jul 30;153(2):187-94. doi: 10.1016/j.jconrel.2011.04.005. Epub 2011 Apr 9.

3.

A novel class of photo-triggerable liposomes containing DPPC:DC(8,9)PC as vehicles for delivery of doxorubcin to cells.

Yavlovich A, Singh A, Blumenthal R, Puri A.

Biochim Biophys Acta. 2011 Jan;1808(1):117-26. doi: 10.1016/j.bbamem.2010.07.030. Epub 2010 Aug 4.

4.

Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.

Kim MS, Lee DW, Park K, Park SJ, Choi EJ, Park ES, Kim HR.

Colloids Surf B Biointerfaces. 2014 Apr 1;116:17-25. doi: 10.1016/j.colsurfb.2013.12.045. Epub 2013 Dec 30.

PMID:
24441178
5.

Improved therapeutic activity of HER2 Affibody-targeted cisplatin liposomes in HER2-expressing breast tumor models.

Alavizadeh SH, Akhtari J, Badiee A, Golmohammadzadeh S, Jaafari MR.

Expert Opin Drug Deliv. 2016;13(3):325-36. doi: 10.1517/17425247.2016.1121987. Epub 2015 Dec 16.

PMID:
26578208
6.

Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine.

Ahlgren S, Wållberg H, Tran TA, Widström C, Hjertman M, Abrahmsén L, Berndorff D, Dinkelborg LM, Cyr JE, Feldwisch J, Orlova A, Tolmachev V.

J Nucl Med. 2009 May;50(5):781-9. doi: 10.2967/jnumed.108.056929. Epub 2009 Apr 16.

7.

Influence of DOTA chelator position on biodistribution and targeting properties of (111)In-labeled synthetic anti-HER2 affibody molecules.

Perols A, Honarvar H, Strand J, Selvaraju R, Orlova A, Karlström AE, Tolmachev V.

Bioconjug Chem. 2012 Aug 15;23(8):1661-70. doi: 10.1021/bc3002369. Epub 2012 Jul 17.

PMID:
22768790
8.

Affibody-displaying bionanocapsules for specific drug delivery to HER2-expressing cancer cells.

Shishido T, Mieda H, Hwang SY, Nishimura Y, Tanaka T, Ogino C, Fukuda H, Kondo A.

Bioorg Med Chem Lett. 2010 Oct 1;20(19):5726-31. doi: 10.1016/j.bmcl.2010.08.011. Epub 2010 Aug 6.

PMID:
20801029
9.

Targeting of epidermal growth factor receptor (EGFR)-expressing tumor cells with sterically stabilized affibody liposomes (SAL).

Beuttler J, Rothdiener M, Müller D, Frejd FY, Kontermann RE.

Bioconjug Chem. 2009 Jun;20(6):1201-8. doi: 10.1021/bc900061v.

PMID:
19435362
10.

Evaluation of maleimide derivative of DOTA for site-specific labeling of recombinant affibody molecules.

Ahlgren S, Orlova A, Rosik D, Sandström M, Sjöberg A, Baastrup B, Widmark O, Fant G, Feldwisch J, Tolmachev V.

Bioconjug Chem. 2008 Jan;19(1):235-43. doi: 10.1021/bc700307y. Epub 2007 Dec 29.

PMID:
18163536
11.

Site-specific radiometal labeling and improved biodistribution using ABY-027, a novel HER2-targeting affibody molecule-albumin-binding domain fusion protein.

Orlova A, Jonsson A, Rosik D, Lundqvist H, Lindborg M, Abrahmsen L, Ekblad C, Frejd FY, Tolmachev V.

J Nucl Med. 2013 Jun;54(6):961-8. doi: 10.2967/jnumed.112.110700. Epub 2013 Mar 25.

12.

Targeted delivery of an anti-cancer agent via steroid coupled liposomes.

Mishra PK, Gulbake A, Jain A, Vyas SP, Jain SK.

Drug Deliv. 2009 Nov;16(8):437-47. doi: 10.3109/10717540903271391.

PMID:
19839788
13.

Focused ultrasound influence on calcein-loaded thermosensitive stealth liposomes.

Novell A, Al Sabbagh C, Escoffre JM, Gaillard C, Tsapis N, Fattal E, Bouakaz A.

Int J Hyperthermia. 2015 Jun;31(4):349-58. doi: 10.3109/02656736.2014.1000393. Epub 2015 Feb 13.

PMID:
25677841
14.

Design of an optimized scaffold for affibody molecules.

Feldwisch J, Tolmachev V, Lendel C, Herne N, Sjöberg A, Larsson B, Rosik D, Lindqvist E, Fant G, Höidén-Guthenberg I, Galli J, Jonasson P, Abrahmsén L.

J Mol Biol. 2010 Apr 30;398(2):232-47. doi: 10.1016/j.jmb.2010.03.002. Epub 2010 Mar 10.

PMID:
20226194
15.

Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer.

Heskamp S, Laverman P, Rosik D, Boschetti F, van der Graaf WT, Oyen WJ, van Laarhoven HW, Tolmachev V, Boerman OC.

J Nucl Med. 2012 Jan;53(1):146-53. doi: 10.2967/jnumed.111.093047. Epub 2011 Dec 15.

16.

Radiolabeled affibody-albumin bioconjugates for HER2-positive cancer targeting.

Hoppmann S, Miao Z, Liu S, Liu H, Ren G, Bao A, Cheng Z.

Bioconjug Chem. 2011 Mar 16;22(3):413-21. doi: 10.1021/bc100432h. Epub 2011 Feb 7.

17.

Thermosensitive liposomes with higher phase transition temperature for targeted drug delivery to tumor.

Chen J, He CQ, Lin AH, Gu W, Chen ZP, Li W, Cai BC.

Int J Pharm. 2014 Nov 20;475(1-2):408-15. doi: 10.1016/j.ijpharm.2014.09.009. Epub 2014 Sep 10.

PMID:
25218394
18.

A two-component drug delivery system using Her-2-targeting thermosensitive liposomes.

Kullberg M, Mann K, Owens JL.

J Drug Target. 2009 Feb;17(2):98-107. doi: 10.1080/10611860802471562 .

PMID:
19089689
19.

Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro system.

Tagami T, Ernsting MJ, Li SD.

J Control Release. 2011 Sep 25;154(3):290-7. doi: 10.1016/j.jconrel.2011.05.020. Epub 2011 May 26.

PMID:
21640149
20.

Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: active ingredient and mediator of drug release.

Lindner LH, Hossann M, Vogeser M, Teichert N, Wachholz K, Eibl H, Hiddemann W, Issels RD.

J Control Release. 2008 Jan 22;125(2):112-20. Epub 2007 Oct 22.

PMID:
18022271
Items per page

Supplemental Content

Write to the Help Desk